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ABSTRACT 
 
 
Acquisition of Cocaine and Heroin Self-administration in  
 
Rats Developmentally Exposed to Lead.  (May 2005) 
 
Angelica Rocha, B.A. California State University San Marcos 
 
Chairs of Advisory Committee: Dr. Jack R. Nation 
                                                  Dr. Paul Wellman 
 
 
          Rationale:  The rate of acquisition of drug self-administration may serve as a predictor 
of later drug-taking behavior, possibly influencing vulnerability to initiate drug use.  
Objectives:  The present study examined the effects of perinatal (gestation/lactation) lead 
exposure on adult rates of acquisition of intravenous (i.v.) heroin self-administration and 
cocaine self-administration using an automated procedure that included both Pavlovian 
and operant components.  Methods:  For Experiment 1, female rats were gavaged daily 
with 0 or 16 mg lead for 30 days prior to breeding with nonexposed males.  Metal 
administration continued through pregnancy and lactation and was discontinued at 
weaning (postnatal day [PND] 21).  Animals born to control or lead-exposed dams 
received indwelling jugular catheters as adults and subsequently were tested daily in a 
preparation where sessions included an initial 3-hr autoshaping period followed by a 3-
hr self-administration period.  During autoshaping, heroin (.018 mg/kg) infusions were 
paired with the extension and retraction of a lever when a lever press was not made for 
15 sec, while infusions occurred during self-administration only when a lever press was 
executed (FR-1).  The criterion for acquisition was a 2-day period during which a mean 
of 10 infusions/session occurred during self-administration.  Animals were given 35 
iv 
days to reach criterion.  Results:  Findings from Experiment 1 showed the proportion of 
rats meeting the lever-press response criterion for heroin when tested as adults was lower 
among lead-exposed animals.  In Experiment 2, cocaine (.20 mg/kg) was presented to 
animals that underwent the same metal-exposure regimen, surgical procedures and 
methods with variations only in the number of infusions that were automatically 
administered during the Pavlovian component.  Criterion for cocaine acquisition was a 
mean of 50 infusions over a two-day. In Experiment 2, a greater proportion of lead-
exposed animals reached the criterion for cocaine acquisition.  Conclusions:  
Developmentally lead-exposed animals showed a decrease in vulnerability to initiate 
drug-taking behavior when presented with heroin in the adult phase, relative to controls.  
In contrast, developmentally lead-exposed animals showed an enhanced vulnerability to 
reach the criterion for cocaine self-administration.  Clinical relevance of developmental 
exposure to lead and the attendant vulnerability to self-administer drugs of abuse is 
discussed.    
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INTRODUCTION 
 Environmental lead emissions plummeted following the phasing-out of leaded 
paint in 1978, and lead-based gasoline in the early 1980’s (Hubbs-Tait, 2005).  However, 
lead continues to be one of the major toxicants in North America producing widespread 
health risks to those who come into contact with the heavy metal.  According to the 
National Health and Nutrition Examination Survey (NHANES) III study (1991-1994) 
there were approximately 900,000 children with blood lead levels that are equal to or 
exceed the level considered “safe” by the Centers for Disease Control and Prevention, 
i.e. 10 µg/dL, compared to about 14 million children in 1978 (Pirkle et al., 1998).   
 A social reality is that economically disadvantaged individuals who lack 
resources to move out of substandard housing in the inner city are at increased risk for 
lead toxicity.  A recent account estimates that 70% of children in inner cities are exposed 
to lead at much higher levels than the general population (Mielke, 1999).  Older homes 
are more likely to contain lead-based alloys and pipes that pollute the water supply and 
increase vulnerability to the adverse side effects produced by lead (Ensminger et al., 
1997).  Soil and dust in impoverished areas, in particular, areas in close proximity to 
highways and deconstruction of old buildings (Manuel, 2003), also contain higher 
concentrations of past emissions from lead-based gasoline and particles from lead-based 
paint that are readily airborne (Lanphear et al., 2002).   
______ 
This thesis follows the style of Psychopharmacology. 
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 In extreme situations, lead poisoning can take the form of encephalopathy, 
characterized by seizures, coma, and death (Rosen and Mushak, 2001).  Over the past 15 
to 20 years, severe acute cases of lead poisoning have declined due to stringent 
governmental regulations (Pirkle et al., 1998).  However, despite this decline, research  
suggests that even present low-level, chronic lead exposure (<10 µg/dL) can produce 
neurophysiological and neurobehavioral deficits (Canfield et al., 2003; Needleman et al., 
1990, 2002; Tong et al., 1998), even in children as young as 3-5 years of age (Canfield et 
al., 2003).  Paradoxically, recent evidence suggests that blood lead levels in children 
may be negatively correlated with IQ scores and ability tests, implying that higher 
concentrations of lead in blood may initiate neuroprotective cellular mechanisms that are 
not activated in the presence of lower blood lead levels [<10 µg/dL] (Bellinger and 
Needleman, 2003).    
 Lead is stored in bone for up to three decades and can be mobilized and released 
into blood plasma during periods of stress and high calcium demands, such as during 
pregnancy (Barltrop, 1968; Gulson et al., 1997; Horiguchi et al., 1959; Roelfzema et al., 
1987) and lactation (Silbergeld, 1991).  Maternal blood lead levels reach a peak during 
the second trimester, at which point the metal is readily transferred to the fetus.  Because 
approximately 45-70% of lead in the blood of reproductive age women originates from 
long-term tissue stores (Gulson et al., 1995), and lead easily crosses the placental barrier 
(Angell and Lavery, 1982; Barltrop, 1968; Weizsaecker, 2003), women exposed to high 
levels of lead prior to more stringent CDC regulations will give birth to children who 
have correspondingly elevated blood lead levels.   
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Absorption and Excretion 
 The deleterious effects of lead appear to begin in utero.  Lead is a particular 
threat to the fetus due to the ease with which it is absorbed by the placenta, crosses the 
underdeveloped blood brain barrier, and penetrates the soft bone structure (Weizaecker, 
2003).  Consequently, children born to lead-exposed mothers may be predisposed in the 
fetal stage and through lactation to develop lead-induced impairments.  Even in older 
children there is increased brain lead absorption and decreased lead excretion, relative to 
adults (Godwin, 2001).  Whereas children absorb up to 50% of ingested lead, adults 
absorb only 10-20% into their bloodstream (Weizaecker, 2003).   
 The primary routes for lead exposure are ingestion and inhalation.  In children 
ingestion occurs primarily via consumption of lead-based paint chips, or contaminated 
soil.  Approximately 5-15% of ingested lead is absorbed by the body and not excreted.  
Of this amount, 95% is concentrated in bone and teeth (Gardella, 2001).  When ingested, 
or absorbed through the skin, lead can be carried in blood plasma and bound to 
hemoglobin.  Lead in blood may have a biological half-life approximating one month, a 
substantially shorter half-life than that of lead in bone [i.e. 20-30 years] (Weizaecker, 
2003).  
 Lead that is inhaled is more easily absorbed than ingested lead.  If inhaled 20% 
to 40% will be absorbed and of that amount, 10%-60% of particles smaller than 5 µg are 
deposited in the lower respiratory tract where they are absorbed by the lung.  Smaller 
lead particles are more likely to be sequestered by kidney where they later can be 
released into the bloodstream.  Larger particles are expelled by the respiratory tract or 
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trapped in mucus secretions and transported by ciliary action to the larynx where lead-
containing particles are ultimately swallowed for more efficient excretion (Barltrop, 
1979).  Thus, residual lead from decades ago may continue to produce exceedingly 
deleterious health deficits that appear to be persistent and irreversible (Canfield et al., 
2003).       
Neurodevelopmental Toxicity  
 There are two general ways in which lead exerts its neurotoxicant effects.  First, 
lead may alter neuropharmacological mechanisms by interfering with chemical 
neurotransmission (Lidsky and Schneider, 2003; Silbergeld, 1992).  Secondly, lead may 
act as a neurodevelopmental toxicant by producing changes in the hardwiring of the 
brain in utero (Moreira et al., 2001; Silbergeld, 1992).  The latter suggestion will be a 
focus in this section.  
 Mechanisms of Action 
 Lead acts as a neurotoxicant by interfering with cellular proliferation, 
differentiation, and synaptogenesis in the fetus and neonate.  Synaptogenesis is a period 
in development characterized by a growth spurt of nerve cells in the developing brain.  
For humans, this period spans the sixth month of gestation through the first few years of 
birth.  In rats, synaptogenesis begins one day prior to birth and terminates on postnatal 
day 14 (Moreira et al., 2001).  During synaptogenesis, lead as well as other non-
competitive and competitive N-methyl-D-aspartate (NMDA) antagonists may prevent 
cells from becoming integrated into a neural network.  If this occurs, inhibitory 
neurotransmitter systems that are late to develop can be prematurely deleted as 
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unnecessary by apoptosis, a process whereby nerve cells are genetically programmed to 
destruct (Moreira et al., 2001).  Learning impairments, attention deficits, and adult onset 
of psychiatric disorders are possible results of lead-induced apoptosis in the developing 
organism.  The consequences may be similar to those of other NMDA receptor 
antagonists such as alcohol, ketamine and phencyclidine (PCP) that disrupt inhibitory 
neurons in the cerebral cortex of the fetus following maternal consumption (Farber and 
Olney, 2003). 
 In addition to cellular changes in utero, lead continues to disrupt cellular activity 
postnatally.  The heme biosynthetic pathway is one of the major sites of lead toxicity.  
By disrupting this pathway, lead impairs the production of hemoglobin, cytochromes, 
catalases, and peroxidases (Warren et al., 1998).  One of two variants of -
aminolevulinic acid dehydratase (ALAD) is genetically present in the human body.  
ALAD-1 is the most common, and ALAD-2 is the least common of the two variants.  
When lead binds to either variant, zinc is displaced and heme biosynthesis is inhibited 
(Warren et al., 1998).  In severe cases, insufficient amounts of hemoglobin may produce 
iron-deficient anemia.  Perhaps related, the same individuals who suffer from 
malnutrition also experience the heaviest lead burdens.     
 ALAD-2, one of the variants of ALAD, may modify the tissue distribution of 
lead in the body by sequestering lead in soft tissue where it is less accessible to the 
central nervous system (CNS).  Thus, ALAD-2 may protect against ultimate toxicity of 
the central nervous system where cognitive impairments are most profound, but enhance 
toxicity of organs, such as kidney (e.g., renal effects), due to the distribution of lead.   
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 Genetics determine which variant of the allele will be expressed.  ALAD-2 
appears to be differentially expressed in ethnic groups, with approximately 11%-20% of 
Caucasians (Benkman et al., 1983) and virtually no African-Americans examined 
expressing this allele.  This is of importance as adolescents carrying ALAD-2 performed 
better on a battery of neuropsychological tests compared to those homozygous for the 
more common variant of ALAD, ALAD-1 (Bellinger et al., 1994).   
 Lead also can interfere with heme biosynthesis by accumulating in and damaging 
mitochondria (Anderson et al., 1996), therein preventing the metabolism of sufficient 
cellular energy, leading to oxidative stress in the cell.  This effect is substantiated by in 
vitro studies of brain capillary endothelial cells showing that lead accumulates in the 
same areas of mitochondria as calcium (Silbergeld et al., 1980).  Lead disruptions of 
mitochondria can also produce excitotoxicity in otherwise normal glutamate 
transmission (Lidsky and Schneider, 2003). 
 As with ALAD-2, glial cells also may serve to protect the CNS against the toxic 
effects of lead.  By sequestering lead, glial cells prevent depletion of oxygen from the 
blood supply via lead-induced oxidative stress (Tiffany-Castigliani, 1989).  Along these 
lines, younger astroglia, rather than older, are more efficient at clearing the blood supply 
of lead.  However, after chronic or elevated blood lead burdens, astroglia may become 
saturated and will gradually release sequestered lead into the brain, further contributing 
to the extended duration of lead effects (Holtzman et al., 1987).   
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 Dietary Deficiency 
 Dietary intake mediates lead absorption and excretion.  Calcium, an essential 
nutrient in the human diet, is a cation that is implicated in the modulation of most 
cellular neurotransmission occurring in the central nervous system.  Lead is a non-
essential cation that mimics calcium-mediated functions; readily substituting for calcium 
when concentrations of calcium are low, or lead is present at high concentrations 
(Hubbs-Tait, 2005). 
 On a molecular level, calcium activates a chain of essential mechanisms involved 
in imperative stages of cellular development, such as proliferation and differentiation.  
These stages of cellular development are mediated by calcium-activated protein kinase C 
[PKC] (Bressler and Goldstein, 1991).  Intracellularly, calcium activates calmodulin 
which stimulates several protein kinases, cyclic-Amp, and phophodiesterases, thus 
affecting potassium channels (Bressler et al., 1999).  Long-term potentiation (LTP), a 
form of neural plasticity believed to be important in learning and memory (Nihei and 
Guilarte, 2001), is also mediated in part by calcium ions acting as second messengers.  
In any of these actions, lead can take the place of calcium and enter an excitable cell that 
ordinarily would allow for the influx of calcium.  Lead also can enter a cell via voltage-
sensitive calcium channels (Kerper and Hinkle, 1997).  The substitution of lead ions for 
calcium ions impedes the natural cascade of calcium-dependent cellular mechanisms, 
and therein, alters neurotransmitter function.  
Calcium, iron, zinc or protein deficiencies that are more frequently encountered 
in economically disadvantaged individuals increase lead absorption (Hubbs-Tait, 2005; 
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Lidsky and Schneider, 2003).  This is a particular concern for women who are pregnant 
or lactating and require additional nutritional supplements for the developing fetus.  
During pregnancy and lactation, in the absence of sufficient micronutrients, lead is more 
readily mobilized from maternal long-term bone stores and directly transferred to the 
fetus.  By increasing lead levels in the fetus, maternal dietary deficiencies predispose 
future generations to lead-induced deficits.  Multiple studies have found that adequate 
nutrient-intake during these periods decreases maternal to fetal transfer of lead via blood 
plasma (Gulson et al., 1997; Johnson, 2001; Tellez-Rojo et al., 2004).   
 Clearly, the need for nutritional intervention remains at a high level.  Low iron 
levels and elevated blood lead levels both are common in minority and economically 
disadvantaged populations.  Anemia that develops from severe or chronic iron 
deficiency is present in a higher percentage of children from low- (29%) rather than 
higher-income (5%) families (Mahaffey, 1995).  Dietary deficiencies suffered during 
crucial developmental years disrupt normal synaptic neurotransmission and exert effects 
that are of long duration.      
Chemical Neurotransmission 
 In addition to lead-induced neurodevelopmental toxicant effects, lead can 
produce neuropharmacological disruptions.  Through childhood and far into adulthood, 
lead continues to be mobilized from bone to blood plasma where it is most active and 
can exert its most deleterious effects.  Lead interferes with normal chemical 
neurotransmission in the brain and many of these effects are irreversible, even at low-
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level chronic doses (Canfield et al., 2003).  This section will focus on 
neuropharmacologically-induced lead effects.   
 Glutamatergic Systems 
 Lead is an antagonist at the glutamate receptor.  It binds noncompetitively at one 
of the four known subunits of glutamate, N-methyl-D-aspartate (NMDA).  In addition to 
NMDA, AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), kainate 
(ionotropic), and g-protein coupled (metabotropic) receptors are known to compose the 
glutamate ion channel.  Lead allows glycine, a coagonist of glutamate, to bind to the 
NMDA receptor, but after depolarization when the magnesium (mg++) block is lifted, 
lead blocks the channel, inhibiting the influx of calcium that would normally 
hyperpolarize the cell (Lasley et al., 2001).  As noted, calcium ions are necessary for a 
multitude of neurodevelopmental processes to occur, particularly in the immature brain.   
 MK-801, a noncompetitive NMDA receptor antagonist, has been used to assess 
the receptor status of NMDA receptors in animals developmentally exposed to lead and 
tested as adults.  Whereas Guilarte et al. (1993) reported a 31% increase in forebrain 
NMDA receptors in lead-exposed rats, Ma et al. (1997) found 15-41% increases in 
NMDA receptors throughout the hippocampus and cortex.  In contrast, 15-30% 
decreases in NMDA receptors in multiple brain regions have been found following 
postweaning lead-exposure (Cory-Slechta et al., 1997).  Lead-induced changes in the 
sensitivity, number of receptors and brain regions affected vary depending on the length 
and time of lead exposure (Lasley et al., 2001).    
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 In adults, lead exposure reduces glutamatergic receptor binding in the frontal 
cortex, basal ganglia and hippocampus.  Dopamine receptor binding and dopamine 
transporter sites also have been reported in these regions (Cory-Slechta, 1995).  By 
reducing glutamatergic activity, lead impairs LTP, perhaps accounting for lead-induced 
cognitive impairments, including spatial memory deficits and lower IQ scores.  Opiates 
such as methadone and morphine exert some effects by acting at the noncompetitive site 
of the NMDA receptor.  Further, correlations have been found between the activation of 
NMDA receptors and resistance to opiates and the development of tolerance (Gies et al., 
1997).  Disturbances of the gamma-amino-butyric-acid (GABA)ergic system in the 
striatum and the hippocampus also have been found (Guilarte et al., 2003). 
 Dopaminergic Systems 
 Dopamine (DA) is the neurotransmitter that is, perhaps, most strongly implicated 
in the reward potency of drugs of abuse, particularly in the mesolimbic pathway system 
that originates in the ventral tegmental area (VTA) and projects to the nucleus 
accumbens (NAcc) and prefrontal cortex.  D1- and D2-like dopamine receptors are the 
most common targets for extracellular dopamine release.  Administering antagonists for  
these receptors alters drug self-administration in rats, typically producing a pattern of 
increasing behavior in a fixed ratio (FR) task, but decreasing behavior during a 
progressive ratio task when the same drug dose is presented (Hubner and Moreton, 
1991).  This pattern of behavior suggests a decrease in the rewarding potency of the 
drug.  Whereas in an FR task animals will emit additional lever presses to obtain 
maximal euphoria when the cost is low (i.e., FR1), in a progressive ratio task where an 
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exponentially greater amount of lever-presses is required for each subsequent infusion of 
drug, lead-exposed animals more readily stop responding.  
 Disruption of dopaminergic functioning that is normally involved in not only 
motor control but also attention, memory and executive functioning can produce a 
multitude of behavioral problems, including attention deficit hyperactivity disorder and 
cognitive impairments (Moll et al., 2001). 
 Studies on alterations to dopaminergic systems following lead-exposure continue 
to yield inconsistent findings.  Chronic, post-weaning exposure to lead has been shown 
to significantly decrease binding of [125] sulpride to D2 receptors in cortical areas, but 
not in the caudate putamen, thalamus, or nucleus accumbens (Ma et al., 1999).  
Conversely, by another account, D2 receptor activity was decreased in the nucleus 
accumbens following postweaning lead exposure with no significant changes observed 
in D1, D2, or dopamine transporter (DAT) changes in the striatum (Pokora et al., 1996).  
One hypothesis suggests that lead depletes dopamine availability, thus, an upregulation 
of D2 receptors would be expected.  However, another hypothesis is that lead stimulates 
an overflow of dopamine into the nucleus accumbens, thus, a down-regulation or 
subsensitivity of D2 receptors would be expected.  The time and length of lead exposure, 
dose of the dopamine agonist used, and dosing-measurement intervals may all contribute 
to differing findings in this area.  What remains clear is that chronic lead exposure 
appears to interact with dopamine neuromechanisms greatly implicated in drug-taking 
behavior.     
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 Cocaine exerts its neurophysiological effects by blocking the dopamine 
transporter and to a lesser extent norepinephrine and serotonin transporters (Rocha et al., 
1998a).  Blockade of the dopamine transporter markedly increases the levels of 
dopamine within the synaptic cleft and the time the neurotransmitter can act on target 
receptors.  This observation is well documented in animal experiments (Self, 2004) and 
supported in human studies (Schlaepfer, 1997).  
 Serotonergic Systems 
 Dopaminergic systems have been of primary focus in the study of drug-induced 
reward potency and dependence for many years.  However, other transmitter systems, 
such as serotonin (5-HT), also are believed to be of importance in drug-seeking/drug-
taking behavior.  There are at least 15 receptor subtypes for 5-HT, each with at least 
three different effector mechanisms, via adenylyl cyclase, phospholipase C, and ion 
channels (Saxena, 1995).   
 In general, serotonin has been found to be sufficient in initiating self-
administration behavior in genetically altered, dopamine-transporter-deficient mice 
(Rocha et al., 1998a).  In a study using 5-HT1B receptor knock-out mice, the absence of 
serotonin 5-HT1B receptors increased the reinforcing effects of cocaine during 
maintenance (Rocha et al., 1998b).  However, Tran-Nguyen et al., (2001) reported that 
5-HT lesions by 5,7 dihydrohytryptamine in cocaine-trained animals attenuated cocaine 
drug-seeking during extinction and attenuated cocaine-induced reinstatement, possibly 
via an increase in 5-HT2C receptors.  These studies suggest serotonin may play different 
roles in cocaine reward depending on the phase of cocaine self-administration.        
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 5HT2c receptors also have been found to inhibit VTA dopaminergic cell body 
firing, likely through an enhancement of GABA function (Di Matteo et al., 1999).  In 
accordance, the 5-HT2c agonist, Ro 60-0175 produced a reduction of extracellular 
dopamine levels in the NAcc and frontal cortex (Millan et al., 1998).  Conversely, the 
selective 5-HT2 antagonist SB 242, 084 increases VTA cell firing and 
accumbens/frontal cortical DA release (Kennett et al., 1997) [see Grottick, 2000].   
 Serotonin 5-HT2  receptors do not exert consistently similar effects on 
neurotransmitter function.  Fluoxetine, a selective serotonin reuptake inhibitor, has been 
found to act through an antagonism of 5-HT2c receptors in addition to blockade of 5-HT 
reuptake, suggesting contrasting actions at these two serotonin receptor subtypes may 
result in an increase of serotonin in the synaptic cleft (Ni and Miledi, 1997).  At this 
juncture, the role of 5-HT as it relates to other drugs has yet to be determined, though a 
decrease in the functioning of the serotonin transporter has been found to mediate 
neuronal changes in chronic cocaine and alcohol users (Little, 1998).    
 Endorphin Systems 
 Opiate receptors in the [VTA] (Van Ree et al., 2000) and possibly the (NAcc) 
play a role in the reinforcing effects of opiates (Xi and Stein, 2002).  The opiate system 
modulates electrical brain-stimulation reward, sexual motivation, and potentiates the 
reinforcing effects of other drugs such as cocaine (Van Ree et al., 2000).  Various 
subtypes of opiate receptors are known to exist.  Mu-opioid receptors are attributed with 
the reinforcing effects of opiates, whereas kappa-opioid receptors may modulate drug-
taking behavior.  A kappa-opioid receptor agonist, U50,488H produced a leftward shift  
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in both morphine and cocaine dose-effect curves, suggesting kappa-opioid agonists may 
increase sensitivity to the rewarding properties of various drugs of abuse (Kuzmin et al., 
1997).   
 The dopaminergic fibers projecting from the VTA to the NAcc are the fibers that 
have been strongly implicated in opiate self-administration (Vezina et al., 1987).  The 
VTA also is the site of many gamma-amino-butyric acid (GABA) neurons, which are 
linked to the dopamine cells in the VTA.  In the absence of substantial VTA mu-opioid 
receptor activation, GABA interneurons modulate glutamate-stimulated dopaminergic 
activity, ultimately constraining the basal firing rate of dopamine projection neurons 
(Koob, 1992).  With the application of morphine, however, there is an inhibitory effect 
of GABA interneurons, resulting in greater glutamate involvement in the region of the 
VTA and a dopamine increase in the NAcc (Kalivas and Duffy, 1995). 
 In addition to GABA, glutamate may be involved in the reinforcing properties of 
opiates.  NMDA glutamate receptors and opiate receptors are co-localized on neurons 
throughout the CNS, suggesting interactions between the two are profound inasmuch as 
depolarization of a single cell may simultaneously excite both receptors (Wang et al., 
1999).  Several cellular models for possible interactions between NMDA and opiate 
receptors have been proposed based on biochemical and physiological evidence.  It is 
generally suggested that mu-opioid receptors modulate subsequent NMDA receptor 
functions through phosphorylation and other second messenger systems (Trujillo, 2003).   
 MK-801 and other NMDA receptor antagonists have been found to block the 
ability of opiates to establish a conditioned place preference [CPP] (Tzsentke et al., 
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1995) and may inhibit the acquisition of morphine self-administration (Semenova et al., 
1999).  These findings are consistent with studies examining lead/opiate interactions, 
inasmuch as they suggest NMDA receptor antagonists, such as lead, modify the 
reinforcing properties of opiates, and thus, vulnerability/susceptibility to use drugs of 
abuse.  
Lead and Behavior  
 Lead exerts neurochemical disturbances that implicate glutamatergic (Lasley et 
al., 2001), dopaminergic (Hu and White, 1994), and GABA systems (McFarland and 
Kalivas, 2001) that are known to modulate drug sensitivity (Cory-Slechta, 1995) and 
may play a role in the neurobehavioral deficits exhibited in developmentally lead-
exposed children.  These deficits are consistent with studies correlating impairments in 
academic achievement with developmental lead exposure.  Deficits in abstract thinking, 
attention span, conceptual reasoning, and visuospatial perception in children with 
moderate to high blood lead levels have been documented (Rosen and Mushak, 2001).  
Disturbingly, children with levels of blood lead below those considered safe exhibit 
increased distractibility, hyperactivity, inability to inhibit inappropriate responding, 
preservation of incorrect responses, poor judgment and impulse control (Brockel and 
Cory-Slechta, 1997; Rice, 1993), and delinquent behavior (Needleman et al., 1996). 
 These problems appear to involve a similar mechanism at the frontal cortex 
(Volkow et al., 2002).  Disruptions to this area produced by developmental lead-induced 
impairments may explain deficits in self-monitoring behavior and inhibitory functioning 
of higher order thinking.  With a decrease in activity of the frontal cortex, cognitive 
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operations that mediate appropriate judgment of behavior is replaced with automatic, 
non-directed, sensory-driven behaviors, such as is seen in drug addiction.   
 One theory is that hypodopaminergic effects impair functioning of  the 
orbitofrontal cortex (OFC) and anterior cingulate gyrus (CG) contributing to compulsive 
behavior and impaired inhibition.  This is particularly a problem for children as the 
frontal cortex is late in developing.  It is of further concern in lead-exposed children who 
have additional developmental delays and hypodopaminergic activity at brain sites 
imperative for self-monitoring behavior (Cory-Slechta, 1997).   
 In addition to direct neurochemical changes in lead-exposed mothers, alterations 
in maternal care have been observed.  In experimental settings, nonexposed and lead-
exposed mothers have shown idiosyncratic quantitative and qualitative differences in 
anal-licking and grooming of respective control and lead-exposed pups.  These 
differences may have an impact on behavioral endpoints that persist into adulthood such 
as drug self-administration patterns (Cuomo et al., 1996).  In experimental work, this 
problem is controlled by using only one pup from each litter to avoid confounds that are 
sometimes evident in studies involving toxic exposure (Holson and Pearce, 1992).  An 
additional concern with maternal lead-exposure is related to stress induced by toxic 
metal exposure.  Studies on maternal stress have shown increased pathologic behaviors 
in pups, such as sensitization to drugs of abuse and delinquent behavior (Cuomo et al., 
1996).  
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Lead/Drug Interactions   
 Time Course of Lead Exposure 
 Cocaine and opiates show contrasting effects of drug potency in animals 
exposed to lead at different developmental stages.  Specifically, animals exposed to lead 
throughout gestation and lactation (perinatally) appear to have an almost uniform 
potentiation for the rewarding efficacy of cocaine when administered chronically.  In 
contrast, animals exposed to lead during adulthood show an almost uniform attenuation 
for the rewarding efficacy of cocaine when administered chronically.  By comparison, 
when opiates, rather than cocaine, are presented repeatedly to animals perinatally 
exposed to lead, or exposed to lead as adults, reinforcement potency is attenuated.  
 Perinatal Lead Exposure 
 In experiments where opiates have been presented repeatedly to animals 
perinatally exposed to lead, a decrease in sensitivity to the drug often is observed.  For 
example, in an intravenous (i.v.) self-administration study rats responded fewer times for 
a heroin reinforcer, at least at intermediate doses (Rocha et al., 2004).  Parallel results 
were obtained when perinatally-exposed animals were tested on a progressive-ratio task, 
i.e., lead-exposed animals ceased lever pressing for heroin reinforcements at lower ratios 
than their control counterparts (Rocha et al., 2004).  In agreement with these findings, 
animals exposed perinatally to lead failed to show a morphine-induced conditioned place 
preference, suggesting a decreased rewarding sensitivity to the opiate (Valles et al., 
2003).  Additionally, in a drug-discrimination study using the kappa-opioid agonist 
U69,539 that attenuates cocaine reinforcement, cocaine discrimination was shown to be 
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impaired in control, but not lead exposed animals (Miller et al., 2001).  Findings further 
suggest developmental lead exposure disrupts the opiate system to a point where the 
reinforcing efficacy of the drug is significantly reduced when animals are tested as 
adults.  
 In contrast to lead/opiate interactions, developmental lead exposure seems to 
potentiate the behavioral effects of cocaine.  That is, perinatal lead exposure increases 
the stimulatory properties of cocaine when animals are tested in a locomotor chamber at 
either postnatal day (PND) 30 or PND 90 (Nation et al., 2000).  Elsewhere, when tested 
in a self-administration paradigm, lead-exposed rats maintained responding at cocaine 
doses too low to sustain responding in untreated controls (Nation et al., 2004).  Also 
employing an i.v. self-administration model, Nation et al., (2003) found that adult rats 
born to dams exposed to lead throughout gestation and lactation exhibited a greater 
inclination to return to drug-seeking at lower doses of a cocaine priming injection.  That 
is, after an extinction period where saline infusions replaced cocaine infusions as the 
reinforcement outcome for lever responding, lead-exposed animals were more likely 
than nonexposed controls to return to self-administration behavior (lever responding) 
following intraperitoneal (i.p.) injections of very low doses of cocaine. 
 The studies noted above suggest the reinforcer potency of heroin is decreased by 
developmental lead exposure and the same metal exposure regime increases the 
reinforcer potency of cocaine.  However, in order to obtain a more complete 
understanding of lead-relate vulnerability to use drugs of abuse, it is necessary to 
examine the drug acquisition phase.   
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 Adult Lead Exposure 
 In the case of cocaine, patterns of drug sensitivity differ depending on whether 
animals are exposed to lead perinatally or during the adult phase.  When animals are 
exposed to low-levels of lead in adulthood, the locomotor-stimulating properties of 
cocaine are attenuated (Nation et al., 1986) and the impact of cocaine on schedule-
controlled operant responding (Burkey et al., 1997) is reduced.  These patterns are 
directionally opposite from those observed in animals exposed to low-levels of lead 
perinatally.   
 Opiate patterns of drug sensitivity differ upon time of lead exposure and task 
examined.  Rats exposed to lead as adults show a reduced behavioral response to 
morphine in a locomotor activity task, relative to control.  However, rats 
developmentally exposed to lead show an enhanced response in the same task (Miller, 
2001).  This pattern of behavior is opposite that observed in self-administration studies 
where an attenuation, not enhancement, of drug responsiveness results with 
developmental lead exposure.  Directionally opposite effects may be due to experimenter 
administered injections, as opposed to i.v. self-administration by the rat, and length of 
drug exposure.   
Vulnerability to Drug Acquisition 
 According to a Substance Abuse and Mental Health Services Administration 
national survey, approximately 25.2 percent of the people who used cocaine in 2002 
were reported to have become dependent on or had become abusers of the drug, whereas 
53 percent of those who used heroin were reported to have become dependent on or 
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abusers of heroin.  Still, as with humans, not all animals that are presented with the 
opportunity to administer drugs of abuse do so.   
 The list of factors that inhibit/expedite acquisition include the following: sex 
differences, appetitive manipulations, impoverished/enriched environment, stress, and 
genetics.  In addition, individual differences such as high levels of locomotor activity in 
a novel environment and greater impulsivity have been shown to be correlated with an 
enhanced vulnerability to initiate drug self-administration (Jentsch et al., 2000). 
 Sex Differences 
 Sex differences have been found to result in differential sensitivity to drugs of 
abuse.  Specifically, female rats exhibited a higher rate of cocaine (.20 mg/kg) and 
heroin (.015 mg/kg) acquisition, as compared to males.  In the case of cocaine, a greater 
percentage of female rats reached the criterion set for acquisition and self-administered 
more drug after acquisition was met (Lynch and Carroll, 1999).  Additionally, a higher 
percentage of females, but not males, bred for high saccharin preference reached 
criterion for cocaine (.20 mg/kg), but not heroin (.015 mg/kg) acquisition (Lynch and 
Carroll, 1999).  Also, females that show preference for high levels of saccharin showed a 
faster rate of cocaine, but not heroin acquisition.  Phenotypical differences were not seen 
with male rats (Carroll et al., 2002), but additional differences in groups that varied by 
sex and/or saccharin preference may have been uncovered if doses on the ascending, 
rather than descending, limb of the dose-effect curve were examined.  
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 Appetitive Manipulations 
 Non-food reinforcers such as running-wheels made available concurrently with 
cocaine also have been shown to impede drug self-administration in females to the point 
where wheel-running substituted for cocaine as a reinforcer.  Varying doses may have 
uncovered differences in male rats (Cosgrove et al., 2002).  A reasonable conclusion is 
that hormonal factors are important in modulating drug self-administration, perhaps as a 
function of estrus cycle in female animals (Lynch et al., 2001, 2002). 
 Restricted access to food also has been shown to facilitate cocaine acquisition in 
an animal model of drug self-administration (Bollweg et al., 1995; Campbell and 
Carroll, 2001).  Further studies showed that food deprivation was a factor in learning, 
not differences in performance such as response speed or reactivity (Bollweg et al., 
1995).  Moreover, food deprivation increases the association between lever pressing and 
a drug reward stimulus.  The increase in learning may be due to food deprivation-
induced increases in plasma corticosterone in rats and cortisol in humans that 
accumulate in the hippocampus, a structure greatly implicated in learning and memory.  
Conversely, blocking the effects of corticosterone with TMT (trimethyltin), a limbic 
forebrain neurotoxin, has been shown to interfere with acquisition of autoshaped lever 
responding during a progressive fixed ratio task.  Further, it was shown that depriving 
the animal to 75% body weight reversed the decline in acquisition rates following TMT 
treatment.  Endogenous glucocorticoids, vasopressin, and catecholamines also may be 
related to the learning enhancement seen following food deprivation (Bollweg et al., 
1995).       
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 Environment 
 The modulating influence of the environment on lead neurotoxicity was 
underscored in a recent study using laboratory rats (Schneider, 2001).  Immediately after 
weaning, rat pups were put in either impoverished or enriched environments.  Half of the 
animals in each environment were exposed to lead via drinking water.  Although by the 
end of testing lead was no longer detectable in the blood and brain of the lead-exposed 
group, lead-exposed rats reared in impoverished environments showed learning deficits.  
Conversely, lead-exposed rats raised in enriched environments performed similarly to 
their unexposed counterparts.  The clinical implications of this study are great, 
suggesting that even when lead burdens on the body are identical and diet remains the 
same, environmental changes are enough to ameliorate lead-induced learning deficits 
(Schneider et al., 2001). 
 Schneider (2001) suggests that environmental factors may modulate the response 
of the brain to a neurotoxin such as lead in the impoverished condition via a decrease in 
neurotrophic factor gene expression in the hippocampus.  Using high-density 
oligonucleotide microarrays, gene expression in young adult mice raised in enriched or 
impoverished environments were analyzed (Rampon et al., 2000).  Neural structure 
during growth and development, synapse formation, synaptic transmission, neuronal 
plasticity, cell survival and neurogenesis (particularly in hippocampal neurons) were 
significantly protected in the group that experienced the enriched environment 
(Kempermann et al., 1997).  
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 Guilarte et al. (2003) also found lead-induced deficits could be reversed by an 
enriched environment.  Animals that were raised in a social and novelty-enriched 
environment, rather than in isolation, showed neuroprotective properties against 
glutamate-mediated disruption of spatial learning and sparing of deficits in glutamate 
subunit, NMDA receptor gene expression (Hubbs-Tait, 2005).   
 Stress 
 Stress has been an environmental factor of much discussion in the vulnerability 
of drug abuse.  Stress induction appears to be directly linked to the activation of the 
hypothalamic pituitary adrenal (HPA) axis (Goeders, 2002a; Goeders, 2002b; Goeders, 
2003).  It is hypothesized that glucocorticoid hormones function in the long-term 
maintenance of the sensitized state, whereas suppression of stress-induced corticosterone 
secretion abolishes the enhanced behavioral responsiveness to amphetamine and 
morphine produced by different stressors (Koob and Le Moal., 1997). 
 Being exposed to high levels of stress in utero may also potentiate the effects of 
lead and produce a susceptibility to use drugs.  Cory-Slechta et al. (2004) exposed dams 
to lead for 2 months prior to breeding them with nonexposed males.  The females were 
either restrained or not on gestation days 16 and 17, days crucial to the development of 
brain structures, such as hypothalamic nuclei, hippocampus, striatum, and frontal cortex 
(Weinstock et al., 1998).  Restraint was conducted for 45 minutes three times on each of 
two days.  Sex differences were found implicating the interaction of sex hormones with 
lead-induced behavioral effects.  Specifically, male offspring born to dams exposed to 
lead and no stress, and females born to lead-exposed dams that experienced stress 
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showed permanently elevated corticosterone levels in offspring.  Paradoxically, males 
born to dams that were exposed to lead and received stress showed slightly decreased 
corticosterone levels.   
 Sex differences are known to mediate stress response.  However, the mechanisms 
by which sex and stress interact remain unclear and outcome measures vary depending 
on factors such as type and duration of the stressor (Faraday, 2002).  Overall, stress-
induced deficits may be produced by elevated corticosterone levels mediating changes in 
mesocorticolimbic function, particularly in the nucleus accumbens and prefrontal cortex.  
Further, this study suggests lead may interact with corticosterone to indirectly enhance 
susceptibility to stress-induced disorders, brain dysfunctions and cognitive deficits 
(Cory-Slechta et al., 2004).       
 Genetics  
 In addition to the environment, genetics also modulate drug self-administration.  
Rats that are genetically bred to exhibit a high (vs. low) response upon presentation of a 
novel environment may also exhibit an increased sensitivity to the rewarding effects of 
hedonic drugs (Hooks et al., 1994; Piazza et al., 1991).  The greater sensitivity in high-
responders may be correlated with a prolonged secretion of corticosterone in the 
hypothalamus-pitutiary-adrenal (HPA) axis in response to stress.  This effect also may 
be mediated by higher sensitivity to the behavioral and dopamine-activating effects of 
glucocorticoids (Koob and Le Moal, 2000). 
 Genetics also may play a role in drug self-administration as seen in studies using 
the cocaine and dopamine reuptake inhibitor, GBR 12909.  GBR 12909 reduced wheel 
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running in hyperactive rats, but not controls (Rhodes et al., 2001).  Compulsivity 
(Werme, 2003), impulsivity (Poulos et al., 1995), and novelty-seeking (Bardo et al., 
1996) also may have a genetic basis that leads to an increase in drug-seeking/drug-taking 
behavior.  
Autoshaping Procedure 
 Most investigations on drug self-administration in animals focus on phases of 
drug use following the initial transition from presentation of the drug to subsequent high 
and stable responding.  Drug maintenance, extinction, and relapse (i.e. varying drug 
doses, organismic and pharmacological manipulations) are all phases of drug-taking that 
are more commonly studied in animal models of drug use/abuse.  In these studies, the 
environment is manipulated in order to accelerate acquisition of the lever-pressing 
response in order to permit detailed assessments of parameters related to drug-selection 
and use.  Techniques such as shaping, a day or more of total food and/or water 
deprivation, priming, etc., are commonly used to accelerate acquisition, therein 
permitting lengthier periods for evaluation of other, relevant issues.     
 In order to examine group differences in vulnerability to initiate drug use, a 
systematic procedure is needed whereby all animals receive the same training to make a 
lever-press response.  The autoshaping procedure serves this purpose, allowing for the 
monitoring of vulnerability to self-administer drugs in control and treated animals in a 
context where shaping methods are uniform and systematic both between and within 
groups.    
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 The autoshaping procedure consists of a combination of Pavlovian and operant 
components wherein animals are first trained that the pairing of an automated retractable 
lever and light cue (conditioned stimuli) and drug infusion (unconditioned stimulus) 
[Pavlovian conditioning] consistently leads to euphorigenic effects.  Subsequent to 
Pavlovian training, rats must learn to press the correct lever (response) in order to 
receive the drug reinforcement (stimulus) [operant conditioning].  This procedure was 
originally developed to train animals to acquire food-reinforced behavior (Brown and 
Jenkins, 1968).  However, more recently, this procedure has been used to study the 
acquisition of drug self-administration in a completely automated procedure, devoid of 
experimenter manipulations that would otherwise vary unsystematically between and 
within groups (Campbell and Carroll, 2000; Carroll and Lac, 1993; Carroll et al., 2002; 
Kakade and Dayan, 2002; Roth and Carroll, 2004).  With autoshaping, the presentation 
of drug and the stimuli associated with the drug infusions during the Pavlovian 
conditioning session is consistent and invariable for all animals (Carroll and Lac, 1993).   
Design and Hypothesis    
 Accordingly, the purpose of the present project was to examine relative 
acquisition rates of psychoactive drug self-administration for offspring (rats) born to 
dams exposed to 0 mg or 16 mg lead (a concentration of lead that is considered to be low 
and clinically relevant) prior to breeding, and throughout gestation and lactation.  In 
Experiment 1, adult control and lead-exposed animals were tested during daily sessions 
that involved an initial 3-hr autoshaping component wherein .018 mg/kg heroin 
infusions were paired with the extension and retraction of a lever (a Pavlovian 
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procedure).  During a subsequent 3-hr self-administration component of each daily 
session, .018 mg/kg heroin infusions were delivered only when a single lever press (FR-
1) was executed (an operant procedure).  In Experiment 2, cocaine (.20 mg/kg) was used 
as the reinforcement outcome.  The methods, apparatus, metal exposure regimen, 
surgical procedures, behavioral endpoints, and all other aspects of the research 
conducted for Experiment 2 will be precisely as described for Experiment 1.  Only the 
number of conditioned drug presentations during the Pavlovian session changed to 
account for differential usage patterns of opiates versus cocaine.  That is, the number of 
infusions self-administered at a dose of .018 heroin (Rocha et al., 2004) are manifold 
lower than those self-administered at a dose of .20 cocaine (Nation et al., 2003); though, 
both doses are on the descending limb of the dose-effect curve for each respective drug.  
Predictions 
 Experiment 1: Heroin 
 Body weights.  Based on previous studies, the analysis of body weights during 
the period of acquisition is not expected to show significant group differences.  Weekly 
fluctuations are expected to occur, but the pattern of change is expected to remain 
constant across groups.  Though the litter size is not expected to be different between 
Group 0-mg and Group 16-mg animals, initial individual pup weights are expected to be 
higher for control versus lead-exposed animals.  However, no differences are expected 
between groups by the beginning of testing.   
 Lead concentrations in tissue.  The mean (SEM) blood lead residue values for 
non-exposed (Group 0-mg) and metal-exposed (Group 16-mg) dams at breeding, 
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parturition, and weaning will be assessed.  Blood lead concentrations for littermates at 
PND 1 and PND 21, as well as for test animals at the termination of the experiment will 
also be determined.  In accordance with previous studies (Nation et al., 2000; 2003; 
2004; Rocha, 2004) for both groups, blood lead levels are expected to fall below 
detectable limits by Day 35 of acquisition testing.  In terms of the analyses that will be 
performed on tissue samples taken from test animals, with the exception of bone (tibia) 
samples for the lead group, tissue concentrations are expected to be the same for both 
exposure conditions.  It is anticipated that lead levels in bone will remain elevated in 
lead-exposed animals due to the extended half-life of lead in bone (Weizaecker, 2003). 
Acquisition of self-administration.  Based on previous literature that suggests a 
pattern of attenuation to the rewarding effects of heroin in rats developmentally exposed 
to lead (Nation et al., 2000; 2003; 2004), a trend should be evident over the 35-day 
testing period for Group 16-mg animals to be less likely to reach the criterion for 
acquisition of heroin self-administration than their control counterparts.  
 A survival analysis is expected to show that Group 16-mg animals acquire at a 
slower rate than control rats.  Proportion tests also will be performed on successive 5-
session blocks and are expected to show a smaller percentage of Group 16-mg animals 
will meet the conditions for acquisition, overall, than Group 0-mg animals.  
 The strength of the differences in group self-administration responding after 
meeting the criterion of 10 infusions/session for 2 consecutive days is expected to be 
reflected in the results from a one-tailed t-test.  If these findings are observed, they will 
suggest perinatal (gestation and lactation) lead exposure results in lower percentages of 
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animals reaching the heroin self-administration acquisition criterion, and that of the 
animals that do acquire, lead-exposed animals will reach criterion at a slower rate. 
 Experiment 2: Cocaine 
 Body weights.  Because animals from Experiment 2 are littermates of Experiment 
1, the analysis of body weights is expected to be the same across studies.  During the 
period of acquisition, weekly fluctuations are expected to occur but the pattern of change 
is expected to remain uniform across groups.  Also, as with Experiment 1, the litter size 
of animals in Experiment 2 should be comparable between Group 0-mg and Group 16-
mg animals.  Though initial individual pup weights are expected to be higher for control 
versus lead-exposed animals, no differences are expected between groups by the 
beginning of testing.   
 Lead concentrations in tissue.  Because animals used Experiment 2 are 
littermates of animals used in Experiment 1, the predictions are the same for Experiment 
2 as they were in Experiment 1.  
Acquisition of cocaine self-administration.  Based on the pattern of potentiation 
to the rewarding effects of cocaine in rats developmentally exposed to lead, a trend 
should be evident over the 35-day testing period for Group 16-mg animals to be more 
likely to meet the requirements for acquisition of cocaine self-administration than their 
control counterparts.  
 As in Experiment 1, survival analysis and a proportion test will be performed to 
assess differences between groups in rate of acquisition and percentage of animals to 
reach acquisition criterion across 5-session blocks.  In contrast to Experiment 1 where 
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heroin will be used, results from Experiment 2 where developmentally lead-exposed 
animals will be presented with cocaine, Group 16-mg animals are expected to reach the 
criterion for cocaine acquisition at a faster rate than control rats.  Proportion tests 
performed on successive 5-session blocks are expected to show that a greater percentage 
of Group 16-mg animals will meet the conditions for acquisition than Group 0-mg 
animals.  
 In Experiment 2 where cocaine will be used, Group 16-mg animals are expected 
to make substantially greater number of active lever responses (receive more infusions) 
than Group 0-mg animals, across the 35-day testing period.  The strength of the 
differences in group self-administration responding after meeting the criterion of 50 
infusions/session for 2 consecutive days is expected to be reflected in the results from a 
one-tailed t-test.  If these findings are observed, they will suggest that perinatal lead 
exposure results in greater percentages of animals reaching the cocaine self-
administration acquisition criterion, and that of the animals that do acquire, lead-exposed 
animals will reach criterion at a faster rate. 
 The results from Experiments 1 and 2 are expected to agree with previous 
findings that suggest developmental exposure to inorganic lead is associated with a 
decreased sensitivity to the reinforcing properties of opiates (Miller et al., 2000, 2001) 
and, conversely, with an increase in sensitivity to the reinforcing properties of cocaine 
(Nation et al., 2000; 2003; 2004).  These effects are expected to translate into similar 
patterns of drug-taking behavior when assessing vulnerability to initiate high and stable 
levels of responding for cocaine or heroin.   
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MATERIALS AND METHODS 
Experiment 1: Heroin 
 Animals 
 All aspects of the research reported here were approved by the Texas A&M 
University Laboratory Animal Care Committee.  For 30 days, adult female Sprague-
Dawley rats (Harlan; Houston, TX) were exposed to 0 (sodium acetate)  or 16 mg lead 
(as lead acetate) daily using a 16 ga gavage needle (Source, Location) to administer the 
respective solutions in a volume of 1.0 ml deionized water.  This procedure has been 
used in previous developmental lead studies to ensure stable blood/tissue levels (cf. 
Nation et al., 2000; 2003; 2004; Rocha et al., 2004).  The present lead concentration was 
selected based on previous studies that found it produces differential behavioral effects 
while not altering dam weights or the locomotor ability of pups (see Miller et al., 2000).  
Following this 30-day toxicant exposure period, females were bred with nonexposed 
males.  Once females tested positive for copulatory plugs the males were removed from 
the home cage.  Females continued to receive their daily doses of the control solution or 
lead acetate solution throughout the gestation and lactation periods.  Standard rat chow 
(Teklad, Madison, WI) and tap water were available ad libitum for dams in the home 
cage.  Litters were culled to eight pups on postnatal day (PND) 1, and only one pup from 
each litter was used in the experiment in order to avoid confounds that are sometimes 
evident in studies involving toxic exposure (Holson and Pearce, 1992). 
 For control and lead-exposed dams, 100-150 µl of tail-blood was drawn at 
breeding, parturition (PND 1), and weaning (PND 21).  In addition, at the point of 
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termination of the experiment, brain, kidney, liver and bone (tibia) were harvested from 
test animals for lead concentration analyses.  Littermates of test animals were sacrificed 
on PND 1 and PND 21, and blood samples were collected for subsequent analyses. 
 The rate of pregnancy was not different between groups.  On PND 21, pups used 
for testing were weaned and housed individually.  All animals were maintained on a 12-
hour light/dark cycle.  Testing commenced at approximately 10:00 hrs, two hrs into the 
12-hr light cycle.      
 Surgical Procedures 
 Surgery was performed at PND 60, which is a point demonstrated to be well 
within the adult timeframe of behavioral change produced by developmental lead 
exposure (Miller et al., 2000; 2001; Nation et al., 2003; 2004).  Using a backplate 
technique, implantation of chronic indwelling jugular catheters was performed using 
sterile techniques.  Rats were anesthetized with separate injections of 50 mg/kg ketamine 
and 50 mg/kg sodium pentobarbital administered intraperioneally (i.p.).  A .01 interior 
diameter (ID) Silastic tubing [Dow Corning, Midland, MI] catheter was inserted into the 
right jugular vein and sutured to muscle tissue in the area of the vein.  Using an 11 ga 
stainless steel tube as a guide, the catheter was passed subcutaneously through the body 
of the animal exiting the back between the scapulae.  A backplate consisting of two 
stainless steel ovals separated by propylene mesh (Ethicon, Inc; Somerville, NJ) 
provided an anchor for a spring leash, through which the catheter was threaded.  
Connecting to the backplate at one end, the other end of the leash was connected to a 
single channel fluid swivel [22 ga] (Instech Labs, Plymouth Meeting, PA).  The swivel 
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design permitted an interlock with separate connecting arms located in the home cage 
and operant test chambers.  The hinged arm allowed for a range of movement in either 
the home cage or test chamber.  A .02 ID catheter continued from the top of the swivel 
to an infusion pump (Razel Scientific Instruments; Stamford, CT) that controlled the 
solution delivery.  Animals were allowed 5 days to recover from surgery before 
commencing heroin self-administration testing.  During this recovery period, each rat 
received in the home cage hourly intravenous (i.v.) infusions (200 µl) of a sterile saline 
solution containing heparin (1.25 U/ml), penicillin g potassium (250,000 U/ml), and 
streptokinase (8,000 U/ml).  Following recovery, animals received automated hourly 
infusions (213 µl) over an 8.00 sec time frame of heparinized saline in the home cage for 
the duration of the study.  
 All animals received free access to food and water for 5 days while recovering 
from surgery.  Subsequently, daily food allotment was restricted to 18 g of standard rat 
chow in order to maintain animals at approximately 85% of the mean body weight of 
non-food-deprived littermates (not participating in the study).  Moderate food restriction 
has consistently been shown to accelerate cocaine acquisition and the procedure is 
recommended for autoshaping acquisition studies (Campbell and Carroll, 2001). 
Uncontaminated water was available ad libitum throughout the study.  Animals were 
weighed daily prior to testing.  Although initial individual pup body weights were higher 
for control versus lead-exposed animals, no group differences in body weight were 
evident at the commencement of testing operations.  Food was placed in home cages 
following the end of each daily testing session.   
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 Apparatus 
 Twelve operant conditioning chambers (Model E10-10, Coulbourn, Allentown, 
PA) in sound attenuating cubicles served as the test apparatus.  Each chamber had two 
levers (left, right) and a stimulus light located above each lever.  Infusion pumps (Razel 
Scientific Instruments; Stamford, CT) controlled drug delivery to each of the boxes.  A 
20-ml syringe delivered i.v. infusions (160 µl) over a 6.00 sec time frame.  The system 
was interfaced with 2 IBM computers, each controlling drug delivery and recording data 
from 6 chambers.  Seven control and 10 lead-exposed animals were run in two squads, 
and subject assignment to chambers and squad was counterbalanced by group. 
 Procedure 
 Autoshaping component.  Each of the 6-hr experimental sessions consisted of 
two parts, an autoshaping and a self-administration component.  Testing was carried out 
seven days per week.  For the first 3 hrs of Experiment 1, during the autoshaping 
component, testing commenced with the retractable lever drawn outside the reach or 
vision of the animal.  After a 480-sec time-out period, the retractable lever extended into 
the operant chamber at which point the animal received a .018 mg/kg heroin infusion if 
it pressed the lever or after 15-sec, whichever occurred first.  Once again, a 480-sec 
time-out period was instituted.  As before, the active lever was then extended into the 
chamber and the animal was given 15-sec to press the lever for an immediate infusion of 
.018 mg/kg heroin, or, if no response occurred, the animal received a noncontingent 
heroin infusion of .018 mg/kg heroin at the end of the 15-sec period.  This cycle repeated 
for the first 20 min of each of the first three hours wherein 5 heroin infusions were 
 35 
administered for a total of 15 heroin infusions over the three hours of autoshaping each 
day of testing. 
 With the chamber house-light off, the stimulus light above the active (right) 
lever was lit for the 6-s duration of the infusion and terminated immediately after.  The 
inactive (left) lever remained extended inside the chamber throughout the study.  
Responses on the inactive lever, as well as responses during an infusion, were recorded 
but had no programmed consequences.  As indicated, a .018 mg/kg heroin infusion (160 
µl) was delivered to the animal following each lever retraction regardless of whether the 
delivery was contingent or noncontingent.  After the first 20 min of each hour, following 
the 5 heroin infusions, all stimulus lights were extinguished and the active lever 
remained retracted for a 40 min time-out session, until testing recommenced at the 
beginning of the next hr.         
 Self-administration component.  For the second 3-hr component of the 
experiment, the retractable lever remained extended and .018 mg/kg heroin infusions 
were contingent upon lever pressing under an FR-1 schedule.  As before, responses on 
the left lever and responses during an infusion delivery were recorded, but had no 
programmed consequences.  At the end of the 3-hr self-administration period, testing 
was concluded for the day.     
 The criterion for acquisition of heroin self-administration was a 2-day period 
during which a mean of 10 infusions/session occurred during the 3-hour operant phase.  
This criterion followed that set by previous studies in the area of acquisition using a 
comparable dose of heroin (Carroll et al., 2002; Lynch and Carroll, 1999).  The heroin 
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dose (.018 mg/kg) was chosen based on data from previous studies that show this dose is 
highly reinforcing, and will produce high and stable rates of responding (Rocha et al., 
2004).      
 In order to confirm patency during acquisition training, catheters were flushed 
twice daily with .20 mls of a heparinized saline solution; once prior to and once 
following each daily testing session.  Catheters of questionable patency were flushed 
with .05 mls of pentobarbital (7.50 mg/ml) followed by .20 mls of heparinized saline, 
and these animals were checked for immediate onset of brief anesthesia.  At the end of 
the study, each animal in both exposure conditions received an i.v. infusion of 7.50 
mg/kg sodium pentobarbital.  Again, catheter patency was verified by rapid onset of 
brief anesthesia. Each of the animals included in this report tested positive for open 
lines.  
 Drugs 
The Research Technology Branch of the National Institute of Drug Abuse 
generously supplied the heroin (diacetylmorphine).  Heparinized saline served as the 
heroin vehicle.  Lead acetate and sodium acetate were obtained from Sigma Aldrich 
Chemical Company (St. Louis, MO).   
 Tissue Collection and Analyses  
 After animals recovered from patency verification, control (Group 0-mg) and 
lead-exposed (Group 16-mg) test animals were anesthetized with sodium pentobarbital 
(50.00 mg/kg, i.p.).  Following blood collection via cardiac puncture, brain was rapidly 
harvested along with kidney, liver, and bone (tibia).  Following collection of blood and 
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tissue samples, lead residues were measured via atomic absorption spectrophotometry as 
described in a detailed report from our laboratory (Dearth et al., 2003). 
 Statistical Procedures  
 The comparative rates of acquisition of cocaine self-administration were 
assessed using the Kaplan-Meier survival analysis, Breslow statistic (Lee, 1992).  This 
analytical procedure is ideally suited for determining differences in rate with respect to 
animals reaching a set criterion (SPSS; Chicago, Il).  Comparative percentages of 
animals reaching criterion between groups was assessed using a proportion analysis 
(Bruning and Kintz, 1997).  In addition, an Analysis of Variance (ANOVA) test was 
performed on the mean number of active lever responses (infusions) and inactive lever 
responses for each group across the course of self-administration testing. 
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RESULTS 
Body Weights 
 The analysis of body weights during the period of acquisition did not show 
significant group differences; F(1,14)= .10, p> .05 (mean body weight = 329.64 g + and  
326.92 g + for Groups 0-mg and 16-mg, respectively).  Weekly fluctuations did occur 
but the pattern of change was uniform across groups.  Though the litter size was not 
different between Group 0-mg and Group 16-mg animals (means = 13.5 and 12.3, 
respectively; p> .05), initial individual pup weights were higher for control versus lead-
exposed animals (t(21)= 3.14, p< .05).  However, as indicated, no differences were seen 
between groups by the beginning of testing.        
Acquisition of Heroin Self-administration 
 Figure 1 illustrates the cumulative percentage of rats in each exposure condition 
meeting criterion for the acquisition of heroin self-administration.  It is visually apparent 
that over the 35-day testing period Group 16-mg animals were less likely to meet the 
requirements for acquisition of heroin self-administration than their control counterparts. 
Although during the first two weeks of testing both groups appeared to have little 
separation, by the third week of testing the separation was evident.  All of Group 16-mg 
animals that would acquire did so before the second week of testing was complete.  
Group 0-mg animals continued to escalate in their rate of acquisition until day 28 of 
testing.   
 Though a survival analysis failed to show differences between groups in rate of 
acquisition (p> .05), proportion tests (Bruning and Kintz, 1997) performed on each of 5-
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session blocks, showed that the percentage of rats that met the lever-press response 
criterion when tested as adults was lower among lead-exposed animals (62.5%; Group 
16-mg), than in controls (87.5%; Group 0-mg), by the end of testing (35 days) [Z 2.13, 
df=1, p< .05)].  Whereas 5 of 8 lead-exposed animals reached criterion for acquisition of 
heroin (10 infusions within the 3-hr instrumental session), 7 of 8 control animals reached 
criterion.   
 Figure 2 profiles the mean number of lever presses for each group across 
successive 5-trial blocks of acquisition training.  Although the group main effect 
(F(1,14)= .003, p> .05) and interaction effect (F(1,14)= .59, p>.05) failed to reach an 
acceptable level for statistical significance, there was an unexpected trend toward higher 
responses from lead-exposed animals.  It is apparent that both groups responded more 
frequently on the active (heroin) lever than the inactive lever that had no programmed 
consequences.  Further, it is clear that both groups had reached asymptote and exhibited 
stable self-administration patterns over the last 10 days of acquisition.    
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Figure 1.  Cumulative percentage (%) of nonexposed (Group 0-mg/N=8) and 
lead-exposed (Group 16-mg/N=8) rats meeting the criterion for the 
acquisition of heroin (.018 mg/kg/infusion) self-administration within the 35-
day limit.  Open symbols and closed symbols represent the nonexposed and 
exposed conditions, respectively.    
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Figure 2.  Mean active and inactive lever responses for heroin (.018 
mg/kg/infusion) in all animals in Group 0-mg lead (N=8) and Group 16-mg lead 
(N=8), across successive 5-session blocks (Experiment 1).  Open symbols and 
closed symbols represent the nonexposed and exposed conditions, respectively.    
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Lead Concentrations in Tissue 
 Table 1 presents the mean (SEM) blood lead residue values for nonexposed 
(Group 0-mg) and metal-exposed (Group 16-mg) dams at breeding, parturition, and 
weaning.  Blood lead concentrations are shown for littermates at PND 1 and PND 21, as 
well as for test animals at the termination of the experiment.  As can be seen, for both 
groups, blood lead levels had fallen below detectable limits by Day 35 of acquisition 
testing (< .5 µg/dl), and in terms of the analyses performed on tissue samples taken from 
test animals, with the exception of tibia samples for the lead group, tissue concentrations 
were the same for both exposure conditions. 
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Table 1.  Mean (SEM) blood and tissue lead concentration values for dams, littermates 
and test animals in Experiment 1. 
Blood Lead Concentration (g/dl) 
  
  Group 0 mg Group 16 mg 
 
Dams 
Breeding 1.7 (.2) 37.1 (.6) * 
  
Parturition (PND 1) 1.1 (.1) 58.8 (.3) * 
 
Weaning (PND 21) 2.3 (.003) 38.9 (.3) * 
 
 
Littermates 
 
PND 1  1.8 (.03) 83.2 (.2) * 
 
PND 21  1.2 (.01) 13.9 (.03) * 
 
 
Test Animals 
 
Termination  < .5 < .5 
 
Tissue Concentrations of Test Animals at Termination (g/g)  
  Group Lead-0 Group Lead-16 
 
Brain  .003 (.001) .006 (.002) 
 
Kidney  .010 (.002) .034 (.003) 
 
Liver  .004 (.001) .006 (.001) 
 
Tibia  .035 (.002)  2.023 (.317) * 
 
The symbol  indicates that control and lead-exposed animals were significantly 
different (p< .05).
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MATERIALS AND METHODS  
Experiment 2: Cocaine 
The purpose of the second experiment was to examine the relative acquisition 
rates, independent of major intrusions, of drug (cocaine) self-administration for offspring 
(rats) born to dams exposed to 0 mg or 16 mg lead prior to breeding, and throughout 
gestation and lactation.  Because opiates and cocaine typically exert differentially 
opposite effects, it was hypothesized that cocaine would produced an increase in 
vulnerability to reach criterion for cocaine acquisition.   
As in Experiment 1, adult control and lead-exposed animals were tested during 
daily sessions that involved an initial 3-hr autoshaping component wherein .20 mg/kg 
cocaine infusions were paired with the extension and retraction of a lever (a Pavlovian 
procedure).  During a subsequent 3-hr self-administration component of each daily 
session, .20 cocaine infusions were delivered only when a single lever press (FR-1) was 
executed (an operant procedure).   
Animals 
All aspects of the research reported here were approved by the Texas A&M 
University Laboratory Animal Care Committee.  Metal exposure regimen, surgical 
procedures, apparatus, tissue collection/analyses and statistical analyses were identical to 
those of Experiment 1 with only the procedure varying slightly to account for differential 
patterns of drug self-administration between opiates and cocaine.   
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Procedure 
Autoshaping component.  Each of the 6-hr experimental sessions consisted of 
two parts, an autoshaping and a self-administration component.  Testing was carried out 
seven days per week.  For the first 3 hrs of Experiment 1, during the autoshaping 
component, testing commenced with the retractable lever drawn outside the reach or 
vision of the animal.  After a 90-sec time-out period, the retractable lever extended into 
the operant chamber at which point the animal received a .20 mg/kg cocaine infusion if 
it pressed the lever or after 15-sec, whichever occurred first.  Once again, a 90-sec time-
out period was instituted.  As before, the active lever was then extended into the 
chamber and the animal was given 15-sec to press the lever for an immediate infusion of 
.20 mg/kg cocaine, or, if no response occurred the animal received a noncontingent 
heroin infusion of .20 mg/kg cocaine at the end of the 15-sec period.  This cycle repeated 
for the first 20 min of each hr for 3 hrs (30 total cocaine infusions). 
With the chamber house-light off, the stimulus light above the active (right) lever 
was lit for the 6-s duration of the infusion and terminated immediately after.  The 
inactive (left) lever remained extended inside the chamber throughout the study.  
Responses on the inactive lever, as well as responses during an infusion, were recorded 
but had no programmed consequences.  As indicated, a .20 mg/kg cocaine HCl infusion 
(160 µl) was delivered to the animal following each lever retraction regardless of 
whether the action was contingent or noncontingent.  After the first 20 min of each of the 
three hours, following the 10 cocaine infusions, all stimulus lights were extinguished and 
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the active lever remained retracted for a 40 min time-out session, until testing 
recommenced at the beginning of the next hr.         
Self-administration component.  For the second 3-hr component of the 
experiment, the retractable lever remained extended and .20 mg/kg cocaine HCl 
infusions were contingent upon lever pressing under an FR-1 schedule.  As before, 
responses on the left lever and responses during an infusion delivery were recorded, but 
had no programmed consequences.  At the end of the 3-hr self-administration period, 
testing was concluded for the day.  
The criterion for acquisition of cocaine self-administration was a mean of 50 
 infusions per day over 2 consecutive daily self-administration sessions.  This value is 
half of what has been set previously in studies that used twice the duration of testing 
time [i.e., 6-hr autoshaping and 6-hr self-administration] (Carroll and Lac, 1997; Carroll 
and Lac, 1998).  The cocaine dose (.20 mg/kg) was chosen based on data from previous 
studies that show this dose is marginally reinforcing and does not produce satiation or 
motoric impairments (Campbell and Carroll, 2001).      
In order to confirm patency during acquisition training, catheters were flushed 
twice daily with .20 mls of a heparinized saline solution; once prior to and once 
following each daily testing session.  Catheters of questionable patency were flushed 
with .05 mls of pentobarbital (7.50 mg/ml) followed by .20 mls of heparinized saline, 
and these animals were checked for immediate onset of brief anesthesia.  At the end of 
the study, each animal in both exposure conditions received an i.v. infusion of 7.50 
mg/kg sodium pentobarbital.  Again, catheter patency was verified by rapid onset of 
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brief anesthesia (50.00 mg/kg sodium pentobarbital).  Each of the animals included in 
this report tested positive for open lines. 
Drugs 
The Research Technology Branch of the National Institute of Drug Abuse 
generously supplied the cocaine HCl.  Heparinized saline served as the cocaine vehicle.  
Lead acetate and sodium acetate were obtained from Sigma Aldrich Chemical Company 
(St. Louis, MO).   
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RESULTS 
Body Weights 
 The analysis of body weights during the period of acquisition did not show 
significant group differences; F(1,15)= .06, p> .05 (mean body weight = 284.09 g + and  
285.85 g + for Groups 0-mg and 16-mg, respectively).  Weekly fluctuations did occur 
but the pattern of change was uniform across groups.  Animals used in Experiment 1 
were littermates in Experiment 2.  Accordingly, data on litter size is the same as in 
Experiment 1.  Litter size was not different between Group 0-mg and Group 16-mg 
animals (means = 13.5 and 12.3, respectively; p> .05), initial individual pup weights 
were higher for control versus lead-exposed animals (t(21)= 3.14, p< .05).  However, as 
indicated, no differences were seen between groups by the beginning of testing.       
Acquisition of Cocaine Self-administration    
 Figure 3 illustrates the cumulative percentage of non-metal (0-mg lead) and 
metal-exposed (16-mg lead) rats meeting criterion (50 lever presses).  Note, the increase 
in the infusion requirement to meet criterion in Experiment 2 corresponds to the greater 
number of lever responses made at a dose of .20 mg/kg in a cocaine dose-effect curve 
(Nation et al., 2003), compared to the lever responses made at a dose of .018 mg/kg in a 
heroin dose-effect curve (Rocha et al., 2004).   
 It is visually apparent that over the 35-day testing period Group 16-mg animals 
were more likely to meet the requirements for acquisition of cocaine self-administration 
than their control counterparts.  Indeed, even by the fifth day of acquisition training, a 
greater number of lead-exposed animals (20%; Group 16-mg) reached criterion than 
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non-exposed animals (0%; Group 0-mg), and this pattern persisted throughout testing. 
This is especially evident at day 17, approximately mid-way through the 35 day testing 
period, where 60% of Group 16-mg animals had reached the acquisition criterion, but 
only 14.29% of Group 0-mg animals had reached criterion.   
 By the end of testing, neither Group 0-mg (42%) [3 of 7] nor Group 16-mg 
(80%) [8 of 10] reached 100% percentages with respect to acquisition criterion.  As 
assessed by survival analysis, lead-exposed animals reached criterion at a faster rate 
across the 35-day testing period than controls [Kaplan-Meier, Breslow statistic (X 
3.89, df=1, p< .05)].  In addition, there was evidence that lead-exposed animals acquired 
at significantly faster rates than controls.  
 In addition to survival analyses, proportion test were performed.  Proportion 
tests showed a significantly greater percentage of Group 16-mg animals reached 
acquisition criterion than Group 0-mg animals during all but the first 5-day block (block 
2, z = 3.03; block 3, z = 4.20; block 4, z = 3.78; block 5, z = 3.78; block 6, z = 3.09; 
block 7, z = 3.09; ps< .05).   
 Figure 4 profiles the mean number of active (infusions) and inactive lever 
responses per five-session blocks for all animals in both exposure conditions.  A 2 
Groups (0-mg, 16-mg) X 2 Levers (active, inactive) X 7 Blocks of 5 Sessions (1-7) 
repeated measures ANOVA was performed on these data, with Levers and Blocks of 5 
Sessions serving as within factors.  Overall, the findings from this analysis revealed that 
lead-exposed rats self-administered cocaine at greater rates than controls.  In addition to 
significant main effects for Levers (F(1,15) =14.95, p<.05) and Blocks of 5 Sessions  
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(F(6,90) = 7.54, p< .05).  Further, it is apparent from Figure 4 that both groups 
maintained stable response rates at the end of the experiment.  
 In addition to a greater percentage of lead-exposed animals reached criterion for 
cocaine acquisition and doing so at faster rates, lead-exposed animals also made 
substantially greater number of lever responses (received more infusions) across the 
remaining sessions than Group 0-mg animals.  The largest separation in the number of 
lever responses and, consequently, drug infusions administered, was seen during the 
fourth 5-day block between Day 16 and Day 20 of acquisition.  During the fourth 5-day 
block, Group 0-mg animals administered less drug (mean= 19.03 infusions) than Group 
16-mg animals (mean= 62.22 infusions) per 3-hour self-administration session.  Animals 
that reached criterion pressed for a comparable number of drug infusions during the last 
5 days of testing, regardless of group (p> .05), with control animals maintaining a trend 
toward fewer responses.   
 The strength of the differences in group self-administration responding after 
meeting the criterion of a mean of 50 infusions/session for 2 consecutive days is 
reflected in the results from the one-tailed t test performed on the data shown in Figure 
4, t(9)=2.22, p< .05).  Thus, not only does perinatal lead exposure result in greater 
percentages of animals reaching the cocaine acquisition criterion and at faster rates, but 
after criterion is reached lead-exposed animals self-administer at greater frequencies 
than non-exposed animals for the duration of testing.     
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Lead Concentrations in Tissue 
The dam and littermate blood data for animals tested in Experiment 2 are 
presented in Table 1 (littermates were used as test animals for Experiment 2).  As is 
presented in Table 2, the only substantial group differences with respect to lead 
accumulation in tissue of test animals was in the analysis of tibia, where greater lead 
residues were evident in Group 16-mg relative to Group 0-mg; p< .05.  As in Experiment 
1, at termination of testing blood lead concentrations in both exposure conditions were  
< .5 µg/dl, i.e., below the limits of detection.  Thus, all differences were observed even 
though lead had cleared blood in lead-exposed animals by the end of testing.    
 
 
 
 
 
 
 
 
 
 
 
 
 52 
Table 2.  Mean (SEM) tissue lead concentration values for test animals in Experiment 2. 
Tissue Concentrations of Test Animals at Termination (g/g)  
 
  Group Lead-0 Group Lead-16 
 
Brain  .004 (.001) .006 (.002) 
 
Kidney  .008 (.001) .031 (.002) 
 
Liver  .004 (.001) .006 (.001) 
 
Tibia  .029 (.003)  1.950 (.338) * 
 
The symbol  indicates that control and lead-exposed animals were significantly 
different (p< .05). 
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 Figure 3.  Cumulative percentage (%) of nonexposed (Group 0-mg/N=7) and 
lead-exposed (Group 16-mg/N=10) rats meeting the criterion for the acquisition 
of cocaine (.20 mg/kg/infusion) self-administration within the 35-day limit.  
Open symbols and closed symbols represent the nonexposed and exposed 
conditions, respectively.    
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 Figure 4.  Mean active and inactive lever responses for cocaine (.20 
mg/kg/infusion) in all animals in Group 0-mg lead (N=7) and Group 16-mg 
lead (N=10), across successive 5-session blocks (Experiment 1).  Open 
symbols and closed symbols represent the nonexposed and exposed 
conditions, respectively.    
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DISCUSSION, SUMMARY AND CONCLUSIONS 
 Employing .018 mg/kg heroin intravenous (i.v.) as the reinforcement outcome in 
a drug self-administration paradigm, the findings from Experiment 1 revealed that 
perinatal exposure to clinically relevant, low-levels of lead resulted in a smaller 
percentage of rats reaching the criterion for heroin acquisition (10 infusions within the 3-
hour instrumental session) during a 35-day training regimen, relative to nonexposed 
controls.  When cocaine (.20 mg/kg) was substituted as the reinforcer in the self-
administration model (Experiment 2) a greater percentage of the developmentally lead-
exposed animals reached criterion for acquisition as compared to control animals.  
Additionally, lead-exposed animals made a greater number of lever responses (self-
administered more cocaine) than nonexposed animals.  Whereas lead exposure appears 
to decrease the rewarding potency of heroin at relatively low doses, there is evidence 
that when animals are presented with cocaine, lead exposure increases the rewarding 
potency of cocaine.    
It is important to note that in the studies where drugs and perinatally (gestation 
and lactation) lead-exposed animals were used, lead had gained clearance from blood, 
brain, liver, kidney and bone (tibia) by the end of testing, yet the altered behavioral 
effects persisted (Nation et al., 2003; 2004; Rocha et al., 2004).  These data suggest 
relatively permanent neuronal alterations in cocaine/dopamine related circuitries occur 
during a critical period of developmental lead exposure.   
Interpretive issues arise from the fact that developmental lead exposure resulted 
in a smaller percentage of animals acquiring heroin self-administration in Experiment 1, 
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but a greater percentage of animals acquiring cocaine self-administration in Experiment 
2.  In the case of heroin, it is possible that the pattern of group separation may derive 
from lead-induced decreases in the reinforcing properties of the drug, and therein, the 
metal functionally decreases the heroin dose.  Conversely, in the case of cocaine, the 
metal functionally increases the cocaine dose.  
This line of reasoning agrees with a recent literature on perinatal lead/heroin 
interactions where it has been shown that developmental lead exposure results in 
decreased sensitivity to the behavioral effects of heroin; whereas under the same testing 
conditions, lead/cocaine interactions are expressed as an increased sensitivity to the 
behavioral effects of cocaine.  Previously, it was mentioned that developmental lead 
exposure produces a downward shift in the heroin dose-effect curve (Rocha et al., 2004) 
and decreases breaking points in a heroin-reinforced progressive ratio paradigm (Rocha 
et al., 2004).  Combined with drug substitution studies (Miller et al., 2001), the available 
data suggest a decreased responsivity, or subsensitivity, to the rewarding potency of 
opiates.  In contrast, an increase in responsivity, or supersensitivity, is evidenced in the 
rewarding potency of cocaine when animals are developmentally exposed to lead.  
Specifically, lead exposure produces a leftward shift in the cocaine dose-effect curve 
(Nation et al., 2004), reinstatement of drug seeking at low doses of a priming injection of 
cocaine occurs at levels that are too low to affect controls (Nation et al., 2003) and 
heightened locomotor activation by cocaine is evident (Nation et al., 2000).  In each of 
these cases, then, animals developmentally exposed to lead expressed an attenuated 
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response to heroin and, conversely, an amplified response to cocaine, relative to 
controls. 
It is reasonable to expect that the changes in the reinforcing and stimulating 
properties of heroin and cocaine engendered by early lead exposure may be associated 
with direct changes in neural pathways associated with drug reward.  Areas that are 
integral in modulating the rewarding effects of drugs with abuse liability also are sites 
for the accumulation and possible negative effects of lead toxicity (Cory-Slechta et al., 
1997).  Gene and protein expression of specific glutamate subunits in the 
morphologically immature brain is known to be impaired by developmental lead 
exposure (Guilarte, 1998; Guilarte and McGlothan, 2003; Guilarte and Miceli, 1992; 
Guilarte et al., 2003).  Perhaps alterations in glutamatergic function contribute to long-
lasting changes of heroin and cocaine effects observed elsewhere and presently in 
Experiment 1 and Experiment 2.  Of course, numerous other transmitter systems, e.g., 
cholinergic processes (Reddy et al., 2003), may concurrently interact to produce a 
manifold change in neural mechanisms in the immature rat brain that produces relatively 
permanent modifications to the sensitivity of drug reward. 
The contrasting effects observed in the rewarding potency of heroin and cocaine 
following developmental lead exposure may be due in part to the differences in 
neurochemical actions of each type of drug.  Lead is known to target the mesolimbic 
dopamine system, most conspicuously projection neurons from the ventral tegmental 
area to the nucleus accumbens (Cory-Slechta, 1995; Tavakoli-Nezhad et al., 2001).  
Because dopamine activity along this circuit is critically involved in mediating cocaine 
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responsiveness (Ranaldi and Wise, 2001; Wise and Bozarth, 1987), disruptions in 
mesolimbic dopamine functioning resulting from the presence of lead may translate into 
an enduring increased sensitivity to cocaine.   
 In the case of heroin, dopamine in the VTA also may mediate opiate reward.  
However, opiates also may be self-administered directly into the NAcc (Smith et al., 
1987) and opiate antagonists administered into the NAcc attenuate i.v. heroin self-
administration (Vaccarino et al., 1985).  In addition, systemic or intra-NAcc 
administration of DA antagonists does not alter i.v. heroin self-administration (Ettenberg 
et al., 1982).  Likewise, destruction of presynaptic DA terminals in the NAcc, using the 
neurotoxic compound 6-OHDA, selectively attenuates cocaine but not heroin self-
administration (Pettit et al., 1984).  These data suggest a dopamine-independent 
mechanism in the NAcc for opiates.   
 Morphological evidence demonstrates that the majority of NAcc neurons are 
GABAergic and comprise the final common-output neurons in the NAcc (Chang and 
Kitai, 1985; Kita et al., 1985).  These medium, spiny GABAergic neurons receive 
multiple inputs including dopamine from the VTA, glutamate from the PFC, and 
enkephalin from local interneurons that all project primarily to the ventral pallidum 
(Sesack and Pickel, 1982).  Opiate reinforcement is also mediated by an indirect 
disinhibition of dopamine neurons in the VTA and a direct inhibition of GABAergic 
output neurons in the NAcc (Bardo, 1998).   
 Glutamate (Glu) system functions also may account for the directionally opposite 
effects observed in heroin and cocaine sensitivity.  Glutamate (Glu) seems to be more 
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greatly implicated in heroin self-administration than cocaine self-administration.  N-
methyl-D-aspartate (NMDA) is a Glu subtype and distinct genes encode NMDA 
receptor properties essential to calcium channel activity modulating drug reward.  
Moreover, lesions of the NAcc core, but not the shell, slightly reduce maintenance of 
heroin self-administration and impair acquisition of heroin responding (Hutcheson et al., 
2001).  The shell mediates the rewarding effects of cocaine, ostensibly via DA pathways.  
Conversely, the core of the NAcc that is essential for the acquisition of heroin self-
administration, but not that of cocaine, mediates changes in NMDA function.  In 
addition, though dopamine in the NAcc is not critical for heroin self-administration, 
intra-Nacc infusions of opiate receptor antagonists reduces heroin reward, eventually 
eliminated heroin self-administration (Vaccarino et al., 1985; 2001).  In view of these 
and other similar findings, it must be considered that distinctive neuroadaptations in 
these regions resulting from perinatal lead exposure may account for the contrasting 
differences in lead-induced heroin or cocaine self-administration.   
 Other more indirect determinants that affect drug sensitivity produced by 
perinatal lead exposure also should be considered.  Because lead-exposed pups initially 
exhibited lower body weights than controls, early malnutrition may have produced 
adverse neuroadaptations that affected later self-administration of drugs.  In addition, 
disturbances in metabolic conversion and drug distribution/absorption may persist for 
lengthy periods following early lead exposure.  Further, it must be considered that 
elevated response rates exhibited by lead-exposed animals may derive from the   
aforementioned increase in activity that is consistently observed with animals exposed to 
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the same regimen employed here (Nation et al., 2000).  However, elevated locomotion in 
lead-exposed animals does not appear to explain the patterns of self-administration 
observed by Nation et al. (2004), where rats emitted fewer responses for the lowest and 
highest doses of cocaine, but pressed more for the intermediate doses.  Pressing for the 
lower doses of drug was decreased suggesting drug self-administration was consistent 
with drug potency and not a confounding effect of locomotor stimulation.     
 Whatever the neurobiological array of events that ultimately results in increased 
acquisition of intravenous cocaine self-administration among animals perinatally 
exposed to lead and tested during the adult cycle, the risk implications are clear.  As 
noted by Carroll and Lac (1997), animal models of acquisition permit an assessment of 
variables that may increase vulnerability to initiate drug-taking.  In these studies, 
developmental lead exposure modulates the likelihood that an animal will self-
administer a drug (heroin or cocaine) at a low dose under conditions where there is no 
prompting to take the drug.  These data may have predictive validity regarding possible 
vulnerability to drug abuse in humans.  Insofar as an environmental event, such as 
chronic low-level lead exposure, increases the choice to use a hedonic drug, abuse 
potential necessarily increases.   
Because early lead exposure consistently has increased the reinforcement 
efficacy of cocaine (present data; Nation et al., 2003; 2004), there may be legitimate 
concerns that lead poisoning elevates the chances for transition from casual drug use to 
compulsive drug-seeking.  In the case of heroin, antagonism of the potency of the drug 
by lead exposure is of concern because it represents a form of functional tolerance that 
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may occasion increased intake at higher doses of the drug.  Previous studies (Campbell 
et al., 1998; Carroll and Lac, 1993) suggest that as dose increases, the likelihood to self-
administer a drug also increases.  Thus, even though self-administration of heroin 
decreased in lead-exposed animals, at higher doses, the susceptibility to administer the 
drug may increase for lead-exposed animals.  The implications are clear; although lead-
induced changes in drug potency may decrease self-administration at the dose of heroin 
tested, in real world situations, individuals exposed to lead during development may 
seek out higher, thus, more dangerous doses of heroin in order to reach an optimal effect 
of the drug (Corrigall and Coen, 1991; Woolverton, 1986).   
Lead may be producing a burden in the organism, affecting drug sensitivity or 
intake via altered molecular mechanisms in a time-dependent manner (Tran-Nguyen et 
al., 1998).  Interaction effects with lead and opiates/cocaine in various behavioral 
measures further suggest that the lead burdens that occur during various periods of 
development are crucial in mediating the resulting behavioral patterns (Miller et al., 
2000; 2001; Nation et al., 2003; 2004; Rocha et al., 2004; Valles et al., 2003).  
Accordingly, data on developmental exposure to lead indicates a more dynamic and 
sometimes directionally opposite pattern of effects in animals exposed perinatally to the 
metal versus later on in adulthood.   
A confounding variable may be that children exposed to lead are more likely to 
live in lower-income communities where the incidence of low maternal IQ, poor diet, 
delinquency and exposure to multiple environmental toxicants are high.  Socioeconomic 
factors that are highly correlated with populations in enriched/impoverished areas are 
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concerns that must be taken into account in the interpretation of epidemiologic findings 
(Hubbs-Tait et al., 2005).   
An expanding literature shows that urban, minority children from low-income 
families are targeted for lead exposure and exhibit unsafe levels of metal-residue (Brody 
et al., 1994).  Inasmuch as the urban sub-population also is presented with increased 
challenges associated with drug use and abuse, the health industry should be especially 
vigilant to potential links between environmental pollution and drug-abuse liability 
(Ensminger et al., 1997).  
Ultimately, drug initiation such as that monitored here in Experiment 1 and 
Experiment 2, may or may not lead to high, stable responding for a given drug, even in 
the presence of environmental pollution.  Genetic predisposition, experiential history, 
psychosocial unrest, and innumerable societal factors are major determinants of this 
complicated health problem.  What the present acquisition findings from Experiment 1 
and Experiment 2 suggest is that the scientific community and health-care providers 
should not ignore the growing literature that shows exposure to lead during development 
may alter drug sensitivity.  This information not only increases our understanding of 
factors that enhance drug intake, but also it enhances our awareness of how 
environmental vectors in drug abuse may suggest preemptive strategies for decreasing 
vulnerability to drug addiction.    
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APPENDIX 
 
FIGURE CAPTIONS 
 
Figure 1. Cumulative percentage (%) of nonexposed (Group 0-mg/N=8) and lead-
exposed (Group 16-mg/N=8) rats meeting the criterion for the acquisition of 
heroin (.018 mg/kg/infusion) self-administration within the 35-day limit. Open 
symbols and closed symbols represent the nonexposed and exposed conditions, 
respectively.    
Figure 2. Mean active and inactive lever responses for heroin (.018 mg/kg/infusion) in 
all animals in Group 0-mg lead (N=8) and Group 16-mg lead (N=8), across 
successive 5-session blocks (Experiment 1).  Open symbols and closed symbols 
represent the nonexposed and exposed conditions, respectively.    
Figure 3. Cumulative percentage (%) of nonexposed (Group 0-mg/N=7) and lead-
exposed (Group 16-mg/N=10) rats meeting the criterion for the acquisition of 
cocaine (.20 mg/kg/infusion) self-administration within the 35-day limit. Open 
symbols and closed symbols represent the nonexposed and exposed conditions, 
respectively.    
Figure 4. Mean active and inactive lever responses for cocaine (.20 mg/kg/infusion) in 
all animals in Group 0-mg lead (N=7) and Group 16-mg lead (N=10), across 
successive 5-session blocks (Experiment 1).  Open symbols and closed symbols 
represent the nonexposed and exposed conditions, respectively.    
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